2[3]Robinson A, Burke J, Robinson S, et al. The effects of etformin on glyceic control and serumlipids in insulin treated NIDDM patients with suboplimal control. Diabetes Care 1998; 21:701.
二级参考文献4
1Smedegaard kristensen J. Brown Fraudsen K, Bayer T, et al. Repaglinide treatment is associated with significantly less sever ehypoglycaelnic events compared to sulphonylureas. Diabetologia 1999 ; 4 ( Suppl. 1 ) : A4.
2Stjth BJ, Woronoff K, Wiernsperger N. Stinulation of the intracellular portion of the human insulin receptory by the antidiabtic drug etforinn. Biochem phaarmaeal 1998; 55 : 533.
3Dipaolo S, Metformin Ameliorates extreme insulin resistance in a patien with anti- insulin receptor antibodies; description of insulin receptor and postreceptor effects in vivo and in vitro, acta endocrinol copenh 1992; 126:117.
4Robinson A, Burke J, Robinson S, et al. The effects of etformin on glyceic control and serumlipids in insulin - treated NIDDM patients with suboplimal metabotiea control. Diabetes Care 1998;21:701 - 704.
